Adagio Therapeutics, Inc. (ADGI) Social Stream



Adagio Therapeutics, Inc. (ADGI): $4.64

0.04 (+0.87%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add ADGI to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#317 of 398

in industry

ADAGIO THERAPEUTICS INC (ADGI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ADGI.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 4 $60 $33 $48.25 $4.55 960.44%
2021-11-29 4 $60 $40 $49.75 $4.55 993.41%
2021-12-14 4 $60 $11 $40.25 $4.55 784.62%
2021-12-16 4 $60 $9 $30 $4.55 559.34%
2021-12-22 4 $40 $9 $17.5 $4.55 284.62%
2022-01-06 4 $40 $6 $16.25 $4.55 257.14%
2022-03-30 4 $40 $6 $15.25 $4.55 235.16%
2022-04-12 4 $9 $6 $7 $4.55 53.85%
2022-04-14 4 $9 $4 $6.333 $4.55 39.19%
2022-08-22 4 $5 $3 $3.833 $4.55 -15.76%

The Trend in the Analyst Price Target


ADGI's average price target has moved down $3.17 over the prior 132 days.

Over the past 48 weeks, ADGI's average upside potential has been 80.91%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-18 NA 60 33 47.50 51.46 -7.7%
2021-09-19 NA 60 33 47.50 51.46 -7.7%
2021-11-15 4 60 33 48.25 20.35 137.1%
2021-12-16 4 60 9 30.00 14.18 111.57%
2021-12-16 4 46 9 26.50 14.18 86.88%

ADGI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.33 0 0 3 1 1 4

The Trend in the Broker Recommendations


ADGI's average broker recommendation rating worsened by 2 over the prior 43 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, ADAGIO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 931.28% of them.
  • In the context of all US stocks, ADAGIO THERAPEUTICS INC's number of analysts covering the stock is greater than 215.88% of them.
  • To contextualize these metrics, consider that out of all US stocks, ADAGIO THERAPEUTICS INC's variance in analysts' estimates is lower than -865.85% of them.
  • ADGI has a greater average analyst price target than 362.52% of stocks in the mid market cap category.

Stocks similar to ADAGIO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABCM, USNA, and SNDL.

What is the outlook for ADGI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!